HomeCancerLeukemia

Leukemia

Dr Dorritie on Unanswered Questions Relating to Upfront Therapy Choice in CLL

Kathleen A. Dorritie, MD, hematologist/medical oncologist, the College of Pittsburgh Medical Middle’s Hillman Most cancers Middle; assistant professor of medication, Division of Oncology,...

Widespread hypertension drug losartan boosts chemotherapy’s capability to beat leukemia

Losartan pill tablets (© Soni's - inventory.adobe.com) COLUMBIA, Mo. — All cancers are troublesome to deal with, and blood cancers are among the...

Novel chemoimmunotherapy method reveals promise for B-cell acute lymphoblastic leukemia in part 1 examine at Fred Hutch

Within the first medical trial of dose-adjusted EPOCH together with inotuzumab ozogamicin (InO) in adults with relapsed or refractory...

Molecular subgroups of T-cell acute lymphoblastic leukemia in adults handled in keeping with pediatric-based GMALL protocols

We investigated 230 grownup T-ALL sufferers enrolled in GMALL registries and trials with a median age of 32 years (vary 17-83 years); of...

Hot Topics